Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Grace Therapeutics, Inc. (GRCE) had Free Cash Flow per Share of $-0.11 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.36M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$-0.27M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.09M |
|
$-3.09M |
|
15.93M |
|
15.93M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$20.52M |
|
$0.01M |
|
$49.28M |
|
$69.81M |
|
$2.31M |
|
-- |
|
$3.94M |
|
$6.25M |
|
$63.55M |
|
$14.28M |
|
$63.55M |
|
13.83M |
|
| Cash Flow Statement Financials | |
$-1.80M |
|
-- |
|
$-0.33M |
|
$22.13M |
|
$20.00M |
|
$-2.13M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.29% |
|
-23.54% |
|
-4.82% |
|
-5.29% |
|
$4.60 |
|
|
Free Cash Flow per Share |
$-0.11 |
$-0.11 |
|